Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report

Chen, San-Chi MD1,2,3,4; Chao, Yee MD, PhD2,3; Yang, Muh-Hwa MD, PhD2,3,4,5

American Journal of Gastroenterology: April 2017 - Volume 112 - Issue 4 - p 659–660
doi: 10.1038/ajg.2017.1
LETTERS TO THE EDITOR
Buy

1Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

2Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan

3Faculty of Medicine, National Yang Ming University, Taipei, Taiwan

4Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan

5Genome Research Center, National Yang Ming University, Taipei, Taiwan

Correspondence: Muh-Hwa Yang, MD, PhD, Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taipei 11217, Taiwan E-mail: mhyang2@vghtpe.gov.tw

The authors declare no conflict of interest.

© The American College of Gastroenterology 2017. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website